NANOMICRO(688690)2025-04-24 13:40Financial Performance - The company's operating revenue for Q1 2025 was CNY 188.59 million, representing a year-on-year increase of 22.39%[4] - Net profit attributable to shareholders reached CNY 29.22 million, a significant increase of 72.98% compared to the same period last year[4] - The net profit excluding non-recurring gains and losses was CNY 25.08 million, reflecting an 85.28% year-on-year growth[4] - Basic earnings per share were CNY 0.0729, up 73.99% from the previous year[4] - The total profit for the first quarter of 2025 was CNY 30,561,117.82, compared to CNY 18,872,862.75 in the same period of 2024, representing a year-over-year increase of 62.5%[18] - The net profit attributable to shareholders of the parent company for Q1 2025 was CNY 29,215,389.59, up from CNY 16,889,348.07 in Q1 2024, reflecting a growth of 73.1%[18] - The basic and diluted earnings per share for Q1 2025 were CNY 0.0729, an increase from CNY 0.0419 in Q1 2024, representing a growth of 74.5%[18] Research and Development - The company's R&D investment totaled CNY 45.69 million, accounting for 24.23% of operating revenue, a decrease of 2.88 percentage points year-on-year[5] - Research and development expenses for Q1 2025 were ¥45,688,886.66, compared to ¥41,775,828.89 in Q1 2024, an increase of 9.1%[17] Cash Flow and Liquidity - The net cash flow from operating activities was negative CNY 5.30 million, a decline of 157.78% compared to the previous year[4] - The operating cash flow for Q1 2025 was negative at CNY -5,302,608.25, a decline from a positive cash flow of CNY 9,177,879.67 in Q1 2024[20] - Cash inflows from operating activities totaled CNY 208,567,680.88 in Q1 2025, compared to CNY 143,694,631.67 in Q1 2024, marking an increase of 45.2%[20] - Cash outflows from operating activities increased to CNY 213,870,289.13 in Q1 2025, up from CNY 134,516,752.00 in Q1 2024, indicating a rise of 58.8%[20] - The net cash flow from investing activities for Q1 2025 was CNY 22,652,504.36, a significant improvement from a negative cash flow of CNY -14,680,684.84 in Q1 2024[21] - The total cash and cash equivalents at the end of Q1 2025 stood at CNY 277,175,586.10, compared to CNY 293,987,971.63 at the end of Q1 2024[21] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,285.47 million, down 1.04% from the end of the previous year[5] - Total assets as of March 31, 2025, were ¥2,285,471,743.28, down from ¥2,309,596,977.25 at the end of 2024[14] - Total liabilities decreased to ¥353,442,368.20 from ¥421,525,181.46, a reduction of 16.1%[15] - Shareholders' equity increased to ¥1,932,029,375.08 from ¥1,888,071,795.79, reflecting a growth of 2.3%[15] Operational Efficiency - The core business of chromatography fillers and media generated approximately CNY 111 million in revenue, a growth of about 10.62% year-on-year[6] - The company is focusing on enhancing quality and efficiency, which has positively impacted revenue and cost management[7] - Total operating costs for Q1 2025 were ¥161,106,017.03, up 24.3% from ¥129,526,550.05 in Q1 2024[17] - Operating profit for Q1 2025 was ¥30,598,775.21, compared to ¥19,332,551.34 in Q1 2024, reflecting a growth of 58.1%[17] Other Comprehensive Income - The company reported a decrease in other comprehensive income, with a net amount of CNY -33,250.09 in Q1 2025, compared to CNY 32,787.55 in Q1 2024[18]